41
Participants
Start Date
February 21, 2025
Primary Completion Date
July 28, 2025
Study Completion Date
July 28, 2025
No intervention
No study drug will be administered as a part of this study.
Salvetti & Llombart Sl, Barcelona
Lead Sponsor
Gilead Sciences
INDUSTRY